← Leaderboards
William Zeigler Potter
Praxis Bioresearch, Llc
$1,453,697
Attributed
$2,907,393
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2020–22$2M$1.5M$1M$500K$0
'20
'21
'22
Funding mix
By agency
NIH$2,907,393 · 1
By mechanism
R44$2,907,393 · 1
Top collaborators
- Sandeep Patil4 shared
Most similar at Praxis Bioresearch, Llc
Same institution · by research overlap
- Sandeep Patil$3,010,314
Others in their field
Other Emerging Leaders on “Alzheimer&Apos”
- Lance Allen Johnson · University Of Kentucky$7,508,882
- Hyacinth Idu Hyacinth · University Of Cincinnati$6,781,590
- Yi Su · Weill Medical Coll Of Cornell Univ$6,486,733
- Julia Tcw · Icahn School Of Medicine At Mount Sinai$6,079,215
- Jessica Brooke Langbaum · Banner Health$6,050,741
- Timothy Yikai Huang · Sanford Burnham Prebys Medical Discovery Institute$5,936,362
Research focus
Alzheimer&AposMental DepressionHigh RiskIntravenous AdministrationFunctional DisabilityLipaseInterestInstitutionalizationAddictionFda ApprovedAbsorptionCognitionIn VitroIn VivoInvestigationCare CostsDesignCaregiver BurdenDopamineAssociated SymptomDoseClinical DataClinical ResearchMoods
Grant awards (4)
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$957,571
R44 · FY2022 · AG
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$50,000
R44 · FY2022 · AG
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$1,451,070
R44 · FY2021 · AG
Novel Dopaminergic Stimulant Prodrug for the Treatment of Apathy in AD$448,752
R44 · FY2020 · AG